Welcome to LookChem.com Sign In|Join Free

CAS

  • or

773139-99-4

Post Buying Request

773139-99-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

773139-99-4 Usage

Type of compound

GABA A receptor positive allosteric modulator

Potential uses

Treatment of disorders such as epilepsy, anxiety, and sleep disorders

Mechanism of action

Modulates the activity of the GABA A receptor, enhancing inhibitory neurotransmission in the central nervous system, suppressing abnormal neuronal activity, and reducing anxiety and seizures.

Preclinical results

Promising

Ongoing research

Evaluating safety and efficacy for therapeutic use.

Check Digit Verification of cas no

The CAS Registry Mumber 773139-99-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,3,1,3 and 9 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 773139-99:
(8*7)+(7*7)+(6*3)+(5*1)+(4*3)+(3*9)+(2*9)+(1*9)=194
194 % 10 = 4
So 773139-99-4 is a valid CAS Registry Number.

773139-99-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(5-chloro-2-fluorophenyl)-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one

1.2 Other means of identification

Product number -
Other names 2-(5-Chloro-2-fluorophenyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:773139-99-4 SDS

773139-99-4Downstream Products

773139-99-4Relevant articles and documents

HCV INHIBITING BI-CYCLIC PYRIMIDINES

-

Page/Page column 37; 38, (2010/10/20)

The present invention relates to the use of bi-cyclic pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to processes for pre

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 773139-99-4